by Mac Slavo | Oct 28, 2020 | Headline News
Pfizer, the drugmaker of one of the COVID-19 vaccines said nearly 36,000 of the volunteers have already received the second of its two-dose of the vaccine. This vaccine is in the very late stages of trials now. The phase three trials are a critical last step needed to...
